Cytokinetics Inc (STU:KK3A)
€ 66.46 -0.44 (-0.66%) Market Cap: 8.99 Bil Enterprise Value: 9.40 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Cytokinetics Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2026 / 04:30 PM GMT
Release Date Price: €54.5 (-0.91%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CYTK.OQ - Cytokinetics Inc
Cytokinetics Inc at Barclays Global Healthcare Conference
Mar 11, 2026 / 04:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay. Anyway, well, since we started a little bit, it's totally on me. I'm Emily Fields covering US biopharma here at Berkeleys, and we are, that's how I pitched because I was like, we got the whole squad. So CEO Robert Gum and.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
EVP of R&D Fatty Malik.

Sung Lee.

--------------------------------------------------------------------------------
Unidentified_3 [3]
--------------------------------------------------------------------------------
CFO.

---------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot